Altimmune ALT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $97.64M+123% | $43.8M-28.5% | $61.28M-66.5% | $183.15M+273% | $49.15M+32.9% | ||
| $233.94M+1.8% | $229.7M+53.6% | $149.54M— | —— | $100.72M+6.1% | ||
| $42K0.0% | $42K0.0% | $42K0.0% | $42K0.0% | $42K0.0% | ||
| $1.67M+36.6% | $1.22M+44.3% | $845K+163% | $321K-36.7% | $507K-6.8% | ||
| $1.43M-51.7% | $2.96M-32.9% | $4.41M+0.2% | $4.4M+50.1% | $2.93M+32.9% | ||
| $334.68M+20.3% | $278.19M+28.4% | $216.62M+15.0% | $188.42M+21.4% | $155.26M+13.1% | ||
| $208K-33.3% | $312K-7.4% | $337K-7.4% | $364K-5.2% | $384K-7.0% | ||
| —— | —— | —— | —— | -$681K— | ||
| $746K-47.6% | $1.43M-4.7% | $1.5M-4.4% | $1.56M-3.3% | $1.62M-1.3% | ||
| $335.63M+19.9% | $279.93M+28.1% | $218.45M+14.8% | $190.35M+21.0% | $157.26M+12.9% | ||
| $1.53M-43.7% | $2.72M-43.4% | $4.8M+465% | $851K-21.0% | $1.08M+410% | ||
| $265K+3.5% | $256K+3.6% | $247K+3.3% | $239K-2.4% | $245K-12.2% | ||
| $11.32M-24.5% | $15M+19.0% | $12.61M+36.7% | $9.22M-5.9% | $9.8M-6.4% | ||
| $34.51M+0.6% | $34.29M+137% | $14.45M+0.8% | $14.33M— | —— | ||
| $5.82M+1.1% | $5.75M-0.7% | $5.8M+6.7% | $5.43M— | —— | ||
| $51.64M-6.2% | $55.04M+67.6% | $32.85M+13.3% | $28.98M+91.9% | $15.1M-4.4% | ||
| $13K+18.2% | $11K+10.0% | $10K+11.1% | $9K+12.5% | $8K+14.3% | ||
| $961.24M+9.3% | $879.29M+8.2% | $812.73M+5.6% | $769.51M+5.7% | $728.12M+5.5% | ||
| -$672.05M-3.5% | -$649.48M-4.4% | -$622.13M-3.2% | -$603.11M-3.8% | -$580.97M-3.5% | ||
| -$5.22M-6.0% | -$4.93M+1.8% | -$5.02M+0.5% | -$5.04M-0.7% | -$5M-0.6% | ||
| $283.99M+26.3% | $224.89M+21.2% | $185.6M+15.0% | $161.37M+13.5% | $142.16M+15.1% | ||
| $335.63M+19.9% | $279.93M+28.1% | $218.45M+14.8% | $190.35M+21.0% | $157.26M+12.9% | ||
| —— | $518K-5.3% | $547K-1.8% | $557K-71.5% | $1.96M-23.9% | ||
| $746K-47.6% | $1.43M-4.7% | $1.5M-4.4% | $1.56M-3.3% | $1.62M-1.3% | ||
| $746K-47.6% | $1.43M-4.7% | $1.5M-4.4% | $1.56M-3.3% | $1.62M-1.3% | ||
| $233.94M+1.8% | $229.7M+53.6% | $149.54M— | —— | $100.72M+6.1% | ||
| $746K-47.6% | $1.43M-4.7% | $1.5M-4.4% | $1.56M-3.3% | $1.62M-1.3% | ||
| $9.79M-20.3% | $12.28M+57.4% | $7.8M-6.8% | $8.37M-4.0% | $8.72M-15.0% | ||
| $34.77M-2.6% | $35.69M+143% | $14.69M+0.8% | $14.57M+5,847% | $245K-85.4% | ||
| $13K+18.2% | $11K+10.0% | $10K+11.1% | $9K+12.5% | $8K+14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Altimmune's total assets?
- Altimmune (ALT) holds $335.6M in total assets, up 113.4% year over year.
- How much debt does Altimmune have?
- Altimmune carries $34.8M in total debt against $284.0M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Altimmune have?
- Altimmune holds $97.6M in cash and equivalents.
- Can Altimmune cover its short-term obligations?
- Its current ratio is 29.56 — current assets exceed current liabilities.
- Where does Altimmune's balance sheet data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
